Stellate ganglion neurons are postganglionic sympathetic neurons located in the stellate (cervicothoracic) ganglion at the junction of the cervical and thoracic sympathetic chains. These neurons provide sympathetic innervation to the head, neck, upper extremities, and heart, regulating cardiovascular function, thermoregulation, and pain perception. Their dysfunction contributes to autonomic failure in multiple system atrophy, Parkinson's disease, and pure autonomic failure.
flowchart TD
IML["Intermediolateral Cell Column\n(T1-T6 Preganglionic)"] -->|"Cholinergic\n(nAChR)"| SG["Stellate Ganglion"]
SG --> CARD["Cardiac Neurons\n(Norepinephrine)"]
SG --> VASO["Vasomotor Neurons\n(Norepinephrine)"]
SG --> SUDO["Sudomotor Neurons\n(Acetylcholine)"]
CARD -->|"Beta-1 Receptors"| HEART["Heart\n(Rate, Contractility)"]
VASO -->|"Alpha-1 Receptors"| BV["Blood Vessels\n(Vasoconstriction)"]
SUDO -->|"M3 Receptors"| SWEAT["Sweat Glands\n(Thermoregulation)"]
SG --> PILO["Pilomotor Neurons\n(Norepinephrine)"]
PILO --> HAIR["Arrector Pili\n(Piloerection)"]
¶ Location and Structure
The stellate ganglion is formed by the fusion of the inferior cervical and first thoracic ganglia:
- Location: Anterior to the neck of the first rib, posterior to the subclavian artery
- Size: ~2.5 × 1.0 × 0.5 cm
- Composition: ~60,000-100,000 postganglionic neurons
- Laterality: Right and left ganglia with slightly different targets
The stellate ganglion contains heterogeneous neuron populations:
| Subtype |
Neurotransmitter |
Primary Target |
Function |
| Cardiac |
Norepinephrine |
SA node, AV node, myocardium |
Heart rate, contractility |
| Vasomotor |
Norepinephrine |
Blood vessels |
Vasoconstriction |
| Sudomotor |
Acetylcholine |
Sweat glands |
Thermoregulation |
| Pilomotor |
Norepinephrine |
Arrector pili muscles |
Piloerection |
Preganglionic input arrives from:
- Intermediolateral cell column (IML): T1-T6 spinal segments
- Cholinergic synapses: Nicotinic receptors on postganglionic neurons
- Viscerotopic organization: Topographic mapping from spinal cord
Most stellate ganglion neurons express the noradrenergic program:
Synthetic Enzymes:
- TH (Tyrosine hydroxylase): Rate-limiting enzyme for catecholamine synthesis
- DDC (DOPA decarboxylase): Converts L-DOPA to dopamine
- DBH (Dopamine β-hydroxylase): Converts dopamine to norepinephrine
- PNMT: Not expressed (no epinephrine synthesis)
Transporters:
- VMAT2 (SLC18A2): Vesicular monoamine transporter
- NET (SLC6A2): Norepinephrine transporter, reuptake
Receptors:
- α2-Adrenergic receptors: Autoreceptors for negative feedback
- Nicotinic ACh receptors: α3β4 subtype for preganglionic input
Sudomotor neurons are cholinergic:
- CHAT: Choline acetyltransferase
- VAChT: Vesicular ACh transporter
- Co-transmission: Often co-express VIP, CGRP
Autonomic neuron specification involves:
- Phox2a/Phox2b: Autonomic nervous system identity
- GATA2/3: Noradrenergic vs cholinergic fate
- Hand2: Sympathetic neuron development
- Ascl1 (Mash1): Early neurogenesis
Stellate ganglion neurons control cardiac function:
Heart Rate:
- Norepinephrine acts on β1-adrenergic receptors
- Increases SA node firing rate (positive chronotropy)
- Enhances AV node conduction velocity
Contractility:
- β1-receptor activation increases Ca2+ influx
- Positive inotropic effect on myocardium
- Enhanced cardiac output
Vasoconstriction:
- α1-adrenergic receptors on vascular smooth muscle
- Increases peripheral vascular resistance
- Elevates blood pressure
Thermoregulation:
- Cutaneous vasoconstriction conserves heat
- Redistributes blood flow to core organs
¶ Sweat Gland Control
Cholinergic neurons innervate sweat glands:
- Muscarinic M3 receptor activation
- Essential for thermoregulatory sweating
- Emotionally-induced sweating (stress response)
MSA prominently affects sympathetic ganglia:
Pathological Features:
- α-synuclein inclusions: GCIs in ganglion neurons
- Neuronal loss: Degeneration of postganglionic neurons
- Gliosis: Reactive glial proliferation
Clinical Manifestations:
- Orthostatic hypotension: Failure of vasoconstriction
- Anhidrosis: Loss of sweating
- Cardiac denervation: Fixed heart rate
Diagnostic Testing:
- MIBG scintigraphy: Reduced cardiac sympathetic innervation
- Thermoregulatory sweat test: Impaired sweating
- Tilt table testing: Orthostatic blood pressure drop
Autonomic dysfunction in Parkinson's disease involves stellate ganglion pathology:
flowchart TD
LB["Lewy Body Pathology\nin Sympathetic Ganglia"] --> NLOSS["Postganglionic\nNeuron Loss"]
NLOSS --> DENERV["Cardiac Sympathetic\nDenervation"]
DENERV --> OH["Orthostatic\nHypotension"]
DENERV --> FHR["Fixed Heart Rate"]
NLOSS --> ANHI["Anhidrosis"]
OH --> FALLS["Falls and\nSyncope"]
Frequency:
- 30-50% of PD patients have orthostatic hypotension
- Often precedes motor symptoms by years
- Lewy body pathology found in sympathetic ganglia
PAF is a primary autonomic neurodegeneration:
- Limited to autonomic system: No motor or cognitive involvement
- Severe orthostatic hypotension: Prominent feature
- α-synuclein pathology: Similar to PD/MSA
- Good prognosis: Non-progressive or slowly progressive
Diabetes mellitus damages sympathetic ganglia:
- Metabolic injury: Hyperglycemia, oxidative stress
- Vascular insufficiency: Microvascular disease
- Clinical overlap: Similar symptoms to neurodegenerative disorders
Diagnostic and therapeutic nerve block:
- Technique: Local anesthetic injection at C6-C7 level
- Indications: Complex regional pain syndrome, refractory arrhythmias
- Effects: Temporary sympathetic denervation of upper body
Surgical or catheter-based ablation:
- Left cardiac sympathetic denervation: For refractory ventricular arrhythmias
- Bilateral denervation: For severe angina
- Mechanism: Reduces cardiac norepinephrine release
| Agent |
Mechanism |
Indication |
| Midodrine |
α1-agonist |
Orthostatic hypotension |
| Droxidopa |
NE precursor |
Neurogenic OH |
| Fludrocortisone |
Mineralocorticoid |
Volume expansion |
| Pyridostigmine |
AChE inhibitor |
Modest OH benefit |
- multiple system atrophy
- Parkinson's disease
- pure autonomic failure
- [Locus Coeruleus
- Multiple System Atrophy
- Parkinson's Disease
- Orthostatic Hypotension
- PAF